General Medicine - DelRicht Research

General Medicine

General Medicine Trials Conducted

General Medicine Participants Enrolled

General Medicine Sites Nationwide

DelRicht Has Supported 14 FDA Approvals in General Medicine

At DelRicht Research, we have a specialized network of sites focused on general medicine, offering unrivaled patient access and investigator support for your research programs. Our commitment to advancing general medical research is reflected in our partnerships with leading physicians and healthcare facilities.

Therapeutic Expertise

Our expertise in general medicine research includes, but is not limited to:

  • Vaccines: Influenza, COVID-19, RSV, Meningococcal, Pneumococcal
  • Cardio & Metabolic: Type 2 Diabetes, Obesity, Dyslipidemia, Cardiovascular Disease, Hypertension, Hypercholesterolemia
  • Pain: Gout, Diabetic Neuropathy, Back Pain, Fibromyalgia, Osteoarthritis, Migraine, Muscle Spasms
  • Genitourinary & Sexual Health: UTI, Contraception, Vasomotor Symptoms, Low Testosterone (Hypogonadism), Chlamydia, HSV-2, Genital Warts
  • Gastrointestinal: Chronic Idiopathic Constipation, Irritable Bowel Syndrome (IBS-C, IBS-D), Gastroesophageal Reflux Disease (GERD/NERD), Metabolic Dysfunction–Associated Steatohepatitis (MASH)
  • Respiratory & Infectious Disease: Asthma, COPD, Chronic Cough, RSV, Influenza

x50 Sites Recognized as Top Enroller Status

x20 First Patient Screened or Enrolled

Capabilities

DelRicht Research’s broad network provides access to diverse general medicine patients and supports high-quality studies with experienced physicians and staff. Key capabilities include:

  • Secure Investigational Product Storage (Including Controlled Substances)
  • Temperature-Controlled Investigational Product Storage
  • Infusion and Injection-Experienced Staff
  • Pulmonary Function Testing (PFT) and Spirometry
  • Cardiac Safety Monitoring (ECG, Holter, Blood Pressure)
  • Metabolic and Endocrine Assessments
  • Gastrointestinal and Hepatic Function Testing
  • Vaccine Administration and Immunogenicity Assessments
  • Digital Health and Remote Patient Monitoring
  • DEA License and CDS Registration
  • Tracking System to Monitor Medical Equipment, Location, Calibration, Usage, and Maintenance
  • Training Tracking System to Monitor Study Staff and Site Certifications and Licensure 

 

17 General Medicine Principal Investigators

300+ Years of Collective PI Experience

Meet Some Of Our Investigators

Patrick Dennis, MD

Board Certified, Emergency Medicine

Jennifer Zomnir, MD

Board Certified, Family Medicine

Melita Tate, MD

Board Certified, Internal Medicine & Pediatric Medicine

Robert Springer, MD

Board Certified, Internal Medicine

Taylor Sanders, MD

Board Certified, Emergency Medicine

Sean Kerby, MD

Board Certified, Emergency & Family Medicine

Case Studies & Trial Highlights

Enrolled 358%

of the Expected Goal in a US-Based Phase 2 IBS-D Trial

Top 5 Enroller

in a Global Phase 2 Obesity Trial, with 0% Discontinuation

First Patient

Randomized in a Phase 3 Osteoarthritis of the Knee Trial

General Medicine FDA Approvals

General Medicine

Site Network of Choice

See Our General Medicine Locations

Let's talk about your next trial.